Anatara Lifesciences’ irritable bowel syndrome trial shows promising progress
27:12
ASX:ANR
Watch the video above for detailed insights and analysis.
Video Details
Featured Companies: ASX:ANR
Recorded:
Stay Ahead
Get the latest market insights and analysis delivered to your inbox.